SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN)
ALXN 182.500.0%Jul 28 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: kenhott12/7/2007 8:05:41 AM
   of 824
 
Press Release Source: Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals to Present Data on Soliris(R) (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting
Friday December 7, 6:30 am ET

CHESHIRE, Conn., Dec. 7 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN - News) today announced that data relating to paroxysmal nocturnal hemoglobinuria (PNH), as well as to Soliris® (eculizumab), a treatment for patients with PNH, will be presented at the 2007 American Society of Hematology Meeting, December 8 - 11 in Atlanta.

The following abstracts will be presented in a poster session on red cell regulation and disorders of production on Monday, December 10, 2007. The session will open at 10:30 a.m. and poster presentations will be held from 5:00 to 7:00 p.m. for each abstract. Additional information can be accessed through the links provided below.

-- Poster # 897-III: "High Incidence of Progression to Chronic Renal
Insufficiency in Patients with Paroxysmal Nocturnal Hemoglobinuria
(PNH)" Dr. Peter Hillmen et al.
-- Location: Hall B3 and B4
-- abstracts2view.com

-- Poster # 891-III: "Sustained Improvements in Transfusion
Requirements, Fatigue and Thrombosis with Eculizumab Treatment in
Paroxysmal Nocturnal Hemoglobinuria" Dr. Gerard Socie et al.
-- Location: Hall B3 and B4
-- abstracts2view.com

-- Poster # 902-III: "Disease-Related Symptoms Reported across a Broad
Population of Patients with Paroxysmal Nocturnal Hemoglobinuria" Dr.
Gabrielle Meyers et al.
-- Location: Hall B3 and B4
-- abstracts2view.com.

The following abstract will be presented in an oral session on red cell regulation and disorders of production on Tuesday, December 11, 2007. The abstract and presentation information can be accessed at the link provided below.

-- Publication Number 840: "Significant Disease Burden in Paroxysmal
Nocturnal Hemoglobinuria Patients with Lower Levels of Hemolysis,
Mild Anemia and Minimal Transfusion: Clinical Improvement with
Eculizumab Therapy" Dr. Monica Bessler et al.
-- Location: Rooms B213-B214
-- Tuesday, December 11, 2007 - 8:45 a.m.
-- abstracts2view.com.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext